Nk cell therapy agent

Skill bg-szy/TOP-SKILLS/skills/awesome-skills/nk-cell-therapy-agent

全球最大的 Claude Code 技能聚合库 · 收录 3900+ 来自 12+ 来源的技能，提供在线搜索与趋势分析看板 / The world's largest Claude Code skill aggregation hub — 3900+ skills from 12+ sources with online search and trend dashboard

Install

npx -y skills add bg-szy/TOP-SKILLS --skill nk-cell-therapy-agent

Assembled from the repository path, not quoted from the project. Check it against their README if it does not work.

2 things to look at

no licenseNo license file was found in the repository. Code published without one is not open source by default, so using it at work is a question for whoever answers licensing questions where you are.
4 stars4 stars. Stars are a popularity signal and not a quality one, but at this level it is likely that nobody has read this closely except its author, and you would be relying on your own review.

What its author says it does

Copied from the file, not written here

AI-powered NK cell therapy design for cancer immunotherapy including CAR-NK engineering, memory-like NK generation, and KIR/HLA matching optimization.

SKILL.md

5.5 KB, as published. Nobody here has run it

NK Cell Therapy Agent

The NK Cell Therapy Agent provides AI-driven design and optimization of natural killer cell therapies for cancer treatment. It covers CAR-NK engineering, cytokine-induced memory-like (CIML) NK generation, KIR/HLA matching, and NK cell expansion optimization.

When to Use This Skill

When designing CAR-NK constructs for tumor targeting.
To optimize KIR/HLA mismatch for allogeneic NK therapy.
For generating memory-like NK cells with enhanced persistence.
When predicting NK cell activation against specific tumor types.
To analyze NK cell receptor repertoires and function.

Core Capabilities

CAR-NK Design: Design chimeric antigen receptors optimized for NK cell biology (NK-specific signaling domains).
KIR/HLA Matching: Predict KIR-HLA interactions for donor selection in allogeneic therapy.
Memory-Like NK Generation: Optimize CIML protocol with IL-12/15/18 cytokine preactivation.
Expansion Optimization: ML models for feeder-free NK expansion conditions.
Tumor Target Prediction: Match NK receptor profiles to tumor ligand expression.
Persistence Enhancement: Engineering strategies for improved in vivo survival.

NK Cell Advantages Over T Cells

Feature	NK Cells	T Cells
MHC requirement	No	Yes
Allogeneic use	Yes (no GVHD)	Limited (GVHD risk)
CRS risk	Lower	Higher
Off-the-shelf	Yes	Autologous typical
Antigen escape	Multiple receptors	Single CAR
Persistence	Shorter	Longer

CAR-NK Architecture

[scFv] - [Hinge] - [Transmembrane] - [Costimulatory] - [Signaling]

NK-Optimized Domains:
- Transmembrane: NKG2D, CD8α, or CD28
- Costimulatory: 2B4, DAP10, or CD28
- Signaling: CD3ζ (with NK-specific adaptations)
- Additional: Cytokine secretion (IL-15), suicide switch

Workflow

Input: Target antigen, tumor type, NK source (PB, UCB, iPSC, cell line).
CAR Design: Generate optimized CAR-NK construct sequence.
KIR Analysis: Determine KIR genotype and HLA matching for donors.
Activation Protocol: Optimize cytokine cocktail for desired phenotype.
Expansion: Design feeder-based or feeder-free expansion protocol.
Quality Prediction: Predict NK product functionality.
Output: CAR sequence, donor recommendations, expansion protocol, QC metrics.

Example Usage

User: "Design a CAR-NK targeting CD19 for B-cell malignancies with enhanced persistence."

Agent Action:

python3 Skills/Immunology_Vaccines/NK_Cell_Therapy_Agent/nk_designer.py \
    --target CD19 \
    --tumor_type b_cell_lymphoma \
    --nk_source ucb \
    --persistence_strategy il15_secretion \
    --costimulatory 2B4_DAP10 \
    --donors donor_hla_kir.json \
    --output carnk_design/

NK Receptor-Ligand Interactions

Activating Receptors:

Receptor	Ligands	Tumor Expression
NKG2D	MICA/B, ULBPs	Stress-induced
DNAM-1	CD155, CD112	Broadly expressed
NKp30	B7-H6, BAG6	Tumor-specific
NKp46	Unknown tumor	Variable
CD16	IgG Fc	ADCC trigger

Inhibitory Receptors:

Receptor	Ligands	Function
KIR2DL1	HLA-C2	Self tolerance
KIR2DL2/3	HLA-C1	Self tolerance
KIR3DL1	HLA-Bw4	Self tolerance
NKG2A	HLA-E	Checkpoint

Memory-Like NK (CIML) Protocol

Cytokine Preactivation:

IL-12 (10 ng/mL) + IL-15 (50 ng/mL) + IL-18 (50 ng/mL)
16-18 hour stimulation
Enhanced IFN-γ, cytotoxicity upon restimulation
Improved in vivo persistence

Clinical Evidence: Effective in relapsed/refractory AML

KIR/HLA Matching Optimization

Missing-Self Recognition:

Donor KIR + / Patient HLA -
Enhanced NK cytotoxicity
Important for allo-HSCT

Prediction Model:

Input: Donor KIR genotype, patient HLA
Output: Predicted NK alloreactivity score
Validated in transplant outcomes

AI/ML Components

CAR-NK Optimization:

Adapted CARMSeD for NK biology
NK-specific signaling domain preferences
Tonic signaling prediction

Expansion Prediction:

Fold-expansion from culture conditions
Phenotype shift modeling
Exhaustion marker prediction

Prerequisites

Python 3.10+
HLA/KIR databases
NK receptor databases
Flow cytometry analysis tools

Related Skills

CART_Design_Optimizer_Agent - For CAR engineering principles
Epitope_Prediction_Agent - For target selection
Flow_Cytometry_AI - For NK phenotyping

Clinical Development

Current CAR-NK Programs:

CD19 CAR-NK (MD Anderson - AML, lymphoma)
NKG2D CAR-NK (various solid tumors)
CD70 CAR-NK (renal cell carcinoma)
HER2 CAR-NK (breast cancer)

Author

AI Group - Biomedical AI Platform